News & Events

Stay up-to-date with the latest news and events from Slingshot Biosciences. Discover our groundbreaking innovations, partnerships, and industry milestones as we drive advances in biotechnology and healthcare.

SITC 2025

Nov 7-8

Slingshot Biosciences and Cellares combine TruCytes™ Biomarker Controls with the Cell Q™ platform to enhance quality and automation in Cell Therapy Manufacturing

Slingshot Biosciences Launches TruCytes™ Potency CD20 & CD34 Stem Cell Gating Controls, Standardizing Critical Readouts While Slashing Variability, Time, and Cost

BioProcessing Summit 2025

August 18 – 19

Slingshot Biosciences Appoints Glenn Bilawsky as CEO to Lead Strategic Expansion across Clinical Trial and Diagnostic Markets

May 28, 2025

Slingshot Biosciences Debuts TruCytes™ Potency—Cell Mimics for Scalable, Reproducible CAR-T Potency Assays

CYTO 2025

May 31 – June 4

PEGS 2025

May 12 – 16

ISCT 2025

May 6-9

Inside Slingshot Biosciences’ On-Demand Synthetic Cell Platform

Slingshot Biosciences Welcomes Visionary Leader and Industry Expert Dr. Nimisha Srivastava as new Chief Operations Officer

December 4, 2024

Tiffany Salas-Morris Joins Slingshot Biosciences as Chief Commercial Officer

By using this website, you agree to the storing of cookies on your device. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy.